For research use only.
Storage
3 years,-20°C,powder
1 years,-80°C,in solvent
Description
GS-621763, an orally bioavailable prodrug of GS-441524, shows a dose-dependent antiviral effect on replication with an EC50 of 2.8 μM, also inhibits reporter SARS-CoV-2 expressing firefly luciferase (SARS-CoV-2 Fluc) replication with EC50 of 0.125 μM.